Paul Hockings

2023

Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats

2022

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease

2022

Multiparametric magnetic resonance imaging allows non-invasive functional and structural evaluation of diabetic kidney disease

2022

Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy

2022

Fatty acids in multiple circulating lipid fractions reflects the composition of liver triglycerides in humans

2021

Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity – authors’ reply

2021

Randomised clinical trial: Semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging

Editorial for “Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort”

Non-Invasive Imaging Biomarkers to Detect Nash in Subjects with NAFLD

2020

HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol

2020

Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data

BIVARIATE MR IMAGING BIOMARKER TO IMPROVE PREDICTION OF ADVANCED FIBROSIS IN SUBJECTS WITH BIOPSY PROVEN NAFLD

2020

Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI

2019

Repeatability and reproducibility of longitudinal relaxation rate in 12 small-animal MRI systems

2018

A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function

2018

Noninvasive preclinical and clinical imaging of liver transporter function relevant to drug-induced liver injury

Variable flip angle 3D ultrashort echo time (UTE) T1 mapping of mouse lung: A repeatability assessment

2017

Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation

2016

Assessing the relationship between lung density and function with oxygen-enhanced magnetic resonance imaging in a mouse model of emphysema

2016

In Vivo Measurements of T2 Relaxation Time of Mouse Lungs during Inspiration and Expiration

COPD Patients Have Short Lung Magnetic Resonance T1 Relaxation Time.

2016

T1 Relaxation Time in Lungs of Asymptomatic Smokers.

Evaluating carotid plaque inflammation in patients with active rheumatoid arthritis (RA) using 3T magnetic resonance imaging (MRI) and Fludeoxyglucose(18F) PET (18FDG-PET) : a pilot study

Accurate T1 mapping for oxygen-enhanced MRI in the mouse lung using a segmented inversion-recovery ultrashort echo-time sequence.

Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition